This application is based upon and claims the benefit of priority from U.S. Patent Application Ser. No. 60/915,990, filed May 4, 2007, the entire disclosure of which is incorporated herein by reference.
The present invention relates to methods, arrangements and systems which can obtain acoustic information associated with a sample using electromagnetic radiation, and more particularly to such methods, systems and arrangements that can obtain viscoelastic properties of the sample by performing highly efficient Brillouin optical spectroscopy and imaging. This invention further relates to methods, arrangements and systems that combine Brillouin spectroscopy or imaging with reflectance, fluorescence, or Raman spectroscopy or imaging for simultaneous multimodal characterization of a sample.
When an electromagnetic radiation or an optical wave is propagated in a medium, it can be scattered inelastically by acoustic phonons inside the material. This process is known as Brillouin scattering. Brillouin scattering involves acoustic phonons, which may be different from Raman scattering that involves vibrational or rotational phonons.
Spontaneous Brillouin scattering involves acoustic phonons that may be present in a material by thermally-induced density fluctuations. Brillouin scattering can be further enhanced, stimulated, or forced by one or multiple optical pump waves with strong intensity. The magnitude and frequency of Brillouin-scattered light, or its optical spectrum, can be determined by characteristics of the acoustic phonons inside the material. The latter may be closely related to mechanical properties of the medium, such as modulus and hypersonic damping coefficient. Such viscoelastic properties therefore may be measurable by examining the Brillouin scattered light. This technique is referred to as Brillouin spectroscopy. Various techniques to detect the Brillouin signal have been widely applied in physics, material science, and mechanical engineering.
Prior Brillouin scattering studies have been also performed on biological samples, such as collagen fibers, cornea, and crystalline lens, ex vivo, as described in J. M. Vaughan and J. T. Randall, “Brillouin-Scattering, Density and Elastic Properties of the Lens and Cornea of the Eye,” Nature, vol. 284, pp. 489-491, 1980, R. Harley, D. James, A. Miller, and J. W. White, “Phonons and Elastic-Moduli of Collagen and Muscle,” Nature, vol. 267, pp. 285-287, 1977, and J. Randall and J. M. Vaughan, “Brillouin-Scattering in Systems of Biological Significance,” Philosophical Transactions of the Royal Society of London Series a-Mathematical Physical and Engineering Sciences, vol. 293, pp. 341-348, 1979. However, the potential of using Brillouin scattering for tissue biomechanics and tissue engineering has not been significantly explored, possibly because of long acquisition times required by the spectral analysis.
Accordingly, there is a need to overcome the deficiencies described herein above, and to provide improved apparatus, systems and processes for analyzing tissue biomechanics using Brillouin techniques.
To address and/or overcome the above-described problems and/or deficiencies, exemplary embodiments of imaging systems, arrangements and processes can be provided that are capable of combining a rapid spectroscopic analysis of Brillouin scattering with high spatial-resolution microscopy to probe a sample such as human tissue or artificially engineered tissue or other natural and synthetic biomaterial and retrieve their biomechanical properties such as complex modulus at the tissue.
In one exemplary apparatus, a novel rapid yet high-resolution spectroscopic analysis can enable the image formation. A pump beam can be scanned over a sample through an objective lens, and Brillouin-shifted optical waves are detected to characterize their Brillouin spectra. The measured spectral features of the Brillouin signal can be used as contrast for imaging; an image can be obtained by use of a proper lookup table or an appropriate processing computational routine. Thin cross-sectional images of a biological sample can be obtained by using a high numerical-aperture objective lens and confocal detection.
In another exemplary apparatus in accordance with the present invention, the rapid spectral analysis can be multiplexed for different regimes. This can include empowering an optical microscope with different spectral modalities. Elastic scattering, Raman scattering, and/or fluorescence as well as Brillouin scattering from a sample can be simultaneously measured and three-dimensionally mapped to obtain a structural, chemical, functional as well as mechanical information of the sample.
Exemplary embodiments of the present invention provide apparatus and methods which can allow information about biomechanical properties of a material, particularly a biomaterial, to be obtained non-invasively. Such exemplary embodiments can find a wide range of applications in biology and medicine as well as tissue engineering. Potential applications of Brillouin microscopy include in situ, or in vivo, real-time characterization of collagen cross-linking, intraoperative characterizations of tissues based on biomechanical properties, in vivo disease diagnosis, intraoperative tumor margin determination, wound healing monitoring and/or tissue ablation monitoring.
For example, using the exemplary embodiments of the present invention, it is possible to obtain the viscoelastic properties of a sample such as biomaterial, by performing highly efficient Brillouin optical spectroscopy or imaging. Further exemplary embodiments of the present invention can further relate to methods, arrangements and systems that combine Brillouin spectroscopy and imaging with reflectance, fluorescence, or Raman spectroscopy and imaging for simultaneous multimodal characterization of a sample.
Thus, in accordance with certain exemplary embodiments of the present invention, arrangements and methods are provided for obtaining information about a sample. For example, in one exemplary embodiment, it is possible (e.g., using a first arrangement) to receive a first electro-magnetic radiation from a sample which is based on a second electro-magnetic radiation forwarded to the sample. The first electro-magnetic radiation can have a first frequency and the second electro-magnetic radiation has a second frequency which is different from the first frequency. The difference between the first and second frequencies can be based on an acoustic wave inside the sample related to at least one characteristic of the sample. For example, such difference can be is between about −100 GHz and +100 GHz and may be based on an acoustic wave inside the sample related to at least one characteristic of the sample. The first arrangement may employ a confocal pinhole or single-mode optical fiber.
Further exemplary embodiments of the present invention can facilitate (e.g., using a second arrangement) a receipt of at least a portion of the first electromagnetic radiation and separate such second electromagnetic radiation into a particular finite number (N) of frequency component radiations. For example, N can correspond to the number of spectrally resolvable elements and, typically, can range from about 10 to 100 for a Fabry-Perot interferometer or a diffractive grating. A plurality of such frequency component radiations can be simultaneously measured by an array of detectors, where the total combined energy of the frequency component radiations may be greater than 1/N times the energy of the received portion of the first electromagnetic radiation.
In addition, according to the exemplary embodiment of the present invention, it is possible (e.g., using a third arrangement) to receive a particular energy of more than 1/N of energy of the third electro-magnetic radiation, and generate information associated with the sample.
According to another exemplary embodiment of the present invention, it is possible (e.g., using a fourth arrangement) to generate information associated with the sample and to create images of the sample based on the information. In addition, it is possible (e.g., using a fifth arrangement) to scan the second electromagnetic radiation or to move the sample to probe different locations in the sample.
According to another exemplary embodiment of the present invention, the information may be related to a difference between the first and second frequencies, an optical energy associated with a particular finite group of frequency component radiations, and/or a linewidth of a plurality of the frequency component radiations, each of which may be associated with a particular frequency. This linewidth can be equivalent to a linewidth of Brillouin scattering, which may be related to an acoustic damping coefficient of the sample. In contrast, a linewidth of each frequency component radiation can be equivalent to an intrinsic spectral resolution of the second arrangement such as, e.g., a spectrometer. The retrieved information can relate to bio-mechanical properties of the sample that include but are not limited to a complex modulus of the sample, a cross linking of collagen or another anatomical structure.
In a still further exemplary embodiment of the present invention, the first arrangement can include a narrow-band spectral filter arrangement which can receive the first electro-magnetic radiation and attenuate at least a portion thereof which has a frequency which is approximately the same as the second frequency.
Still further exemplary embodiments of the present invention can provide (e.g., using another first arrangement) for a receipt of a first electro-magnetic radiation and a second electro-magnetic radiation provided from a sample, where the first and second electro-magnetic radiations may be based on a third electro-magnetic radiation forwarded to the sample. The first electro-magnetic radiation can have a first frequency, and the second electro-magnetic radiation can have a second frequency and the third electro-magnetic radiation can have a third frequency which may be different from the first frequency. A difference between the first and third frequencies can be based on an acoustic wave inside the sample which may be related to at least one characteristic of the sample. The second electromagnetic radiation can be based on at least one of an elastic scattering, a Raman scattering or a fluorescence within the sample.
In another exemplary embodiment of the present invention, it is possible (e.g., using such other first arrangement) to separate the first and second electro-magnetic radiations into first and second frequency component radiations, respectively. A narrow band spectral separating arrangement can be provided to separate the first electro-magnetic radiation, and a broadband spectral separating arrangement configured to separate the second electro-magnetic radiation. For example, it is possible (e.g., using another second arrangement) to simultaneously detect the first and second frequency component radiations, and to generate information associated with the sample based on the first and second frequency component radiations.
In another exemplary embodiment of the present invention, it is possible (e.g., using another third arrangement) to image the portion of the sample based on the information.
These and other objects, features and advantages of the present invention will become apparent upon reading the following detailed description of embodiments of the invention, when taken in conjunction with the appended claims.
Further objects, features and advantages of the present invention will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the present invention, in which:
Throughout the figures, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components or portions of the illustrated embodiments. Moreover, while the subject invention will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments. It is intended that changes and modifications can be made to the described embodiments without departing from the true scope and spirit of the subject invention as defined by the appended claims.
The phase matching conditions between the pump and scattering light and the acoustic wave can be expressed as:
ωA=ωp−ωs; (1)
{right arrow over (k)}A={right arrow over (k)}p−{right arrow over (k)}s, (2)
where ω and k are angular frequency and wave number, respectively, and the subscript A, p, and s represent the acoustic phonons, pump and scattering (or signal) photons, respectively.
The frequency of the phase matched phonons, e.g., a difference between the pump and scattering photons, can be expressed as:
where n is a refractive index of the sampled material, V is a sound velocity inside the medium, and θ is an angle between incident and scattered optical radiation. When the two waves propagate at the opposite direction, e.g., θ=180 deg, the magnitude of Brillouin shift can attain a maximum value.
The linewidth of Brillouin radiation can be expressed as:
where α represents an attenuation coefficient of the sound wave inside the sample.
The magnitude of the scattered radiation can provide additional information related to the coupling of acoustic and optical energy inside the sample and can be determined by the scattering cross section RB, as described in H. Z. Cummins and R. W. Gammon, “Rayleigh and Brillouin Scattering in Liquids—Landau-Placzek Ratio,” Journal of Chemical Physics, vol. 44, pp. 2785-&, 1966:
where VINT is the interaction volume inside the sample, k is the Boltzmann constant, T is the temperature, ρ is the density of the material, and
can represent an electrostriction coefficient of the material.
Once the acoustic wave is initially developed, the Brillouin phenomenon may be accelerated because of the presence of the scattered light. The scattered light, coherent with the pump light, can amplify the resonant acoustic wave which in turn enhances the Brillouin scattering. This positive feedback can result in strong Brillouin shifted scattered light, a process which may be referred to as stimulated Brillouin scattering. Typically, a Stokes Brillouin component (e.g., having a frequency down shifted) may be predominantly generated in the stimulated scattering process. The process can also be enhanced or forced when two monochromatic pump waves with frequencies separated by νA are incident on a sample, as described in T. Sonehara and H. Tanaka, “Forced Brillouin Spectroscopy Using Frequency-Tunable Continuous-Wave Lasers,” Physical Review Letters, vol. 75, pp. 4234-4237, 1995. When the frequency difference is matched to one of the acoustic phonon frequencies in the sample, multiple Brillouin lines can be generated.
Brillouin interaction is typically a bulk phenomenon measuring bulk acoustic modes. However, as the sizes of the analyzed samples shrink or the opacity of materials increases, boundary effects can become significant in Brillouin scattering. Confined acoustic modes can be preferentially enhanced depending on the geometrical properties of analyzed environments such as size and shape of boundaries or of their individual constituents. An example of this effect is Brillouin scattering from thin films where optical radiation can be dominantly scattered by a surface acoustic wave that determines a dynamical deformation of the sample border known as surface-ripple, as described in R. Loudon, “Theory of Surface-Ripple Brillouin-Scattering by Solids,” Physical Review Letters, vol. 40, pp. 581-583, 1978. Recently, confined acoustic modes have also been observed in nanoparticles, as described in H. S. Lim, M. H. Kuok, S. C. Ng, and Z. K. Wang, “Brillouin observation of bulk and confined acoustic waves in silica microspheres,” Applied Physics Letters, vol. 84, pp. 4182-4184, 2004. For example, empirically, the limit on the dimensions at which bulk Brillouin interactions may be observable has been evinced to be a few acoustic wavelengths, e.g., ≈λP/2n.
Brillouin spectroscopy is a technique that can measure a spectrum of Brillouin scattered light with respect to the pump waves, thereby probing the characteristics of acoustic phonons in a medium. Under certain conditions, it can serve as a mechanical fingerprint of the medium. For example, mechanically, Brillouin scattering can monitor the stress response of a sample to a one-dimensional sinusoidal strain of high frequency (GHz). For viscoelastic materials, the stress of the sample can be determined by a complex longitudinal modulus (M=M′+iM″) whose real part expresses the elastic response and whose imaginary part expresses the viscous response, e.g., the loss of acoustic energy in the sample. The acoustic parameters directly measured (V and α) can be related to the longitudinal modulus through the density ρ of the material [3], e.g.:
M′=ρV2; M″=2ρV3α/νB. (6)
In exemplary embodiments of the present invention, a two-dimensional or three-dimensional microscopic mapping of the mechanical properties of a material, in particular a biological sample, can be constructed by using rapidly acquired Brillouin spectroscopic signatures as contrast. In an exemplary embodiment of the present invention, a pump or probe beam may be scanned laterally across the sample and spectral patterns from each region are recorded to create an image. Light can be scanned with various conventional scanners including, e.g., galvanometer-mounted mirrors, polygonal mirror scanners and/or MEMS mirrors. Another exemplary embodiment of the present invention can use a scanning mechanism located on a fiber-optic catheter or endoscope for an application to, for example, luminal organ imaging.
In principle, three independent parameters can be extracted by each collected spectrum and can serve as contrast mechanisms for imaging: Brillouin frequency shift (Eq. 3), Brillouin linewidth (Eq. 4), and Brillouin intensity (Eq. 5). All of these three properties can have peculiar signatures (e.g., elasticity, viscosity and electrostriction, respectively) of the sampled material. Thus, three separate images can be obtained, for example, using a false color lookup table, featuring such properties. Alternatively, the three pieces of information can be used simultaneously for higher accuracy, especially at the interfaces between two different materials. For example, at the borders of the objects, a non-trivial imaging processing procedure can be applied rather than a simple false-color lookup table. At the interfaces, Brillouin lines of both materials can be measured, proportionally to the amount of incident light that excites each particular material. Therefore, rather than relying on only one of the spectral signatures, the various Brillouin lines can be discriminated, and their total strength can be accurately quantified and compared to the strength that would be observed away from an interface.
Possible light sources which may be used include, e.g., monochromatic lasers emitting a wavelength in the range of visible to infrared. The light source can employ an optical arrangement to deliver more than one frequency line. The linewidth of the laser may be typically less than about 1 MHz, which can provide temporal coherence longer than the lifetime of acoustic phonons. The scattered light 33 from a sample may include multiple frequency components originated from simple elastic scattering, as well as Brillouin scattering.
Exemplary applications for microscope implementation include, e.g., wide-field or confocal microscopy, dual-axis confocal microscopy (see T. D. Wang, M. J. Mandella, C. H. Contag, and G. S. Kino, “Dual-axis confocal microscope for high-resolution in vivo imaging,” Optics Letters, vol. 28, pp. 414-416, 2003) and/or fiber confocal microscopy. In an exemplary embodiment of the present invention, an epi-detection configuration may be used in which a backward-propagating Brillouin light 33 is collected by the same lens 31 used for illumination. Epi-detection can take advantage of an intrinsic property of Brillouin scattering, e.g., the scattered signal wave can be a phase conjugate to the pump wave. This property may enhance the collection efficiency of the Brillouin wave through a turbid medium such as tissue.
Exemplary focusing mechanisms are shown in
More than one pump beam may be provided using multiple objective lenses.
The requirements on spectral analysis for Brillouin spectroscopy can be stringent because 0.1 GHz to 50 GHz features may be resolved. High spectral resolution and rapid analysis can be essential to facilitate imaging capabilities as well as dynamic studies.
High resolution and simultaneously high sensitivity in the spectral analysis can be important. Fabry-Perot interferometry can be used for the spectral analysis of Brillouin signal in both scanning (see J. R. Sandercock, “Some Recent Developments in Brillouin-Scattering,” Rca Review, vol. 36, pp. 89-107, 1975) and non-scanning configurations (as described in K. J. Koski, J. Muller, H. D. Hochheimer, and J. L. Yarger, “High pressure angle-dispersive Brillouin spectroscopy: A technique for determining acoustic velocities and attenuations in liquids and solids,” Review of Scientific Instruments, vol. 73, pp. 1235-1241, 2002). Fabry-Perot scanning interferometers can have very high resolution. However, they can be intrinsically slow because they perform the spectral analysis in a sequential manner by measuring the energy of the various frequency components one at a time. Non-scanning (or angle-dispersive) Fabry-Perot interferometry may be faster because it can measure all frequency components at once in a parallel fashion using an array of detectors. However, angle-dispersive Fabry-Perot interferometry may also have intrinsic limitations in sensitivity as described below.
In angle-dispersive Fabry-Perot spectroscopy, the spectral separation can be determined by the interference of multiple reflections at two optical mirrors. Two interference patterns can be formed, one in transmission and one in reflection, but only the transmission pattern may be measured by the detecting device. All energy of the reflected interference pattern can be lost, thereby hindering the sensitivity of the spectrometer.
The maximum amount of light that may be forwarded to the detector in this configuration can be easily quantified. The resolution performance of spectrally dispersive elements can be characterized by a parameter known as finesse (f), which may be defined as a ratio of the separation between different orders of diffraction to the linewidth of an individual resolved line. The finesse f can be similar to the number of spectral components can be resolved; e.g., f=N. A higher finesse can correspond to a higher resolution of the spectral dispersive element.
However, in angle dispersive Fabry-Perot interferometry, for each frequency component that is discriminated in the transmitted pattern, a certain, proportional, amount of light may be lost in the reflected pattern. Thus, a higher finessecan correspond to a lower total light throughput. If f is the finesse of the angle-dispersive Fabry-Perot interferometer, then a maximum of 1/f of the input light can be sent to the detecting device. This is a limit which does not include other practical loss mechanisms. The 1/f throughput limit can be overcome by various other spectral dispersive elements such as, e.g., diffraction gratings or prisms, but such devices cannot provide the high resolution needed for Brillouin spectroscopy.
The simultaneous requirements of resolution and light throughput can be met by a fully parallel-detection spectroscopic technique. A preferred solution for such spectroscopy is shown in
the exemplary VIPA spectrometer generally may have a limited resolution of about 1 GHz and a limited extinction efficiency of about 30 dB (1 over a thousand) and, as a result, may be effective only for optically transparent samples. In a turbid sample such as a biological tissue, elastic (Rayleigh) scattering can be several orders of magnitude stronger than Brillouin scattering and is separated by only a few GHz from Brillouin signal. For this reason, additional spectral selection may be preferable. Possible solutions include diffraction gratings, fiber Bragg gratings, or notch filters based on narrow absorption line of gas cells. Two further procedures may be used, e.g., a multiple VIPA spectrometer and a spatial-to-spectral VIPA notch filter.
This approach can be extended further to three or more VIPA stages to improve contrast, but additional stages may increase optical loss. Besides the intrinsic losses of a VIPA, a single VIPA stage can produce multiple diffraction orders, but only one or a few of them may be transferable to another VIPA at the next stage. Even with optimal optical design, a total loss of 6 to 10 dB may result. These additional losses can be compensated by increasing CCD integration time or by spectrum averaging. Moreover, improving the extinction of the spectrometer greatly reduces the problem arising from the backscattered light, thereby allowing for more efficient collection procedures.
For specific situations in which high spectral resolution and contrast are needed a scanning filter such as a Fabry-Perot interferometer can be used. The Fabry-Perot scanning interferometer may have a free spectral range of 50 GHz, and finesse of 1000; it can operate in single-pass configuration or in multipass, fixed or tandem, to enhance contrast. Alternatively, a fixed filter with a bandpass, notch, or edge type may be used, instead of a scanning filter, to measure the magnitude of certain frequency components. However, an optical frequency of the pump wave should be stabilized or locked with respect to the fixed filter.
Further exemplary embodiments of the present invention can be provided which combine exemplary embodiments described herein above with different spectral modalities. For example, once light is delivered to a material, the light collected from the sample can include various components arising from different phenomena which may carry independent information about the sample under study.
In exemplary embodiments of the present invention, a combination of Brillouin microscopy with other modalities can be provided. An exemplary block diagram of such multi-modal microscopy via the simultaneous implementation of Brillouin as well as Raman and fluorescence spectroscopy is shown in
Beam 157, containing Brillouin reflectance and rotational Raman information, can be analyzed by a spectrometer 161 and a detector 162. Exemplary solutions for this analysis can include various spectrometers as described herein above. Beam 159, containing fluorescence and Raman scattering, can be further spectrally separated by a dispersive element 163, whose exemplary implementations are gratings, bandpass filters, prisms or other conventional spectral dividing methods. The fluorescence beam 165 is collected and measured by a detector 167; the vibrational Raman component 169 is collected and measured by a detector 171. Exemplary solutions for detectors 169, 171, 162 include, but are not limited to, photomultiplier tubes or photodiodes, or they can be combined in a single array detector such as, e.g., a CCD camera. Such detectors can allow delivery of Raman, Brillouin and fluorescent information simultaneously to the same computer 173.
This multi-modality technique and apparatus can be particularly advantageous because, as previously stated, the various processes can be used to sample independent and diverse characteristics of a given material, thus yielding mechanical as well as optical and/or chemical information about the analyzed sample.
A typical spectrum recorded from water in 1 s under 10 mW of illumination power is shown in
Several spectra acquired from different materials using this prototype instrument are shown in
Rapid data acquisition achievable by parallel detection can be critical for following dynamic processes that may change the elastic properties of materials in real time. Such a capability is shown in
No previous data was available for comparison to such observations. However, the experimental result corresponds to the expected time-dependent curing process, because UV curing can induce crosslinking in a polymer adhesive and thereby increase its modulus. This experiment demonstrates the capability of exemplary embodiments of the present invention to monitor mechanical changes associated with crosslinking of a polymer with a high sensitivity (e.g., 40 MPa/√Hz) and a high temporal resolution (e.g., about 1 sec).
Three-dimensional Brillouin microscopy can be achieved using exemplary embodiments of the present invention that include a confocal arrangement. For imaging, Brillouin spectra can be acquired continuously as the sample is translated with respect to the beam focus. The spatial resolution of an exemplary confocal apparatus was observed to be about 6 μm in a transverse direction and 60 μm in an axial direction. Resolution measurements were obtained by recording Brillouin frequency shifts at the interface of two materials by over-sampling the acquisition data to a much smaller step than the actual resolution. At the interface of two materials, Brillouin signatures from both materials were observed, having different strengths depending on the amount of light that is shining onto a particular material. A meaningful parameter retrieved for such measurement can be a ratio between Brillouin signal amplitudes in the two frequency regimes that correspond to the two different materials.
To demonstrate cross-sectional imaging, an intraocular polymer lens, e.g., a popular biomedical implant used to replace a human crystalline lens, was used as a sample. The intra-ocular lens is made of acrylate-methacrylate copolymer with bonded UV absorber and blue-light filtering chromophore (transmission of about 90% at 532 nm) to mimic the performance of human lenses. To minimize backscattering and back-reflections, the intraocular lens was placed in a bath of epoxy resin of similar refractive index, inside a plastic cuvette, and the sample was slightly tilted with respect to the optical axis as shown in
Certain previous exemplary data have been collected with a single VIPA spectrometer. Thus, such data may be limited to optical transparent samples. According to one exemplary embodiment of the present invention, by using an exemplary tandem VIPA spectrometer, the extinction can be improved significantly and therefore more scattering samples can be analyzed.
Using an exemplary tandem VIPA spectrometer, it may be possible to measure, e.g., the Brillouin signature from crystalline lens of a mouse eye in vivo.
Based on such exemplary data, Brillouin Microscopy can be used as a preferable non-invasive diagnostic tool in, e.g., ophthalmology for early diagnosis, treatment evaluation and scientific understanding of ocular diseases such as presbyopia and cataracts. The exemplary embodiments of the present invention can also be used for various other applications, including and not limited to, e.g., auxiliary instruments for surgical treatments of cataracts, to monitor the procedure and/or evaluate pre- and post-surgical biomechanical signatures.
Exemplary embodiments of the present invention can be used in a variety of fields other than ophthalmology, as indicated by the preliminary exemplary data obtained using the exemplary embodiment of the system described herein above. One such exemplary application may be, e.g., to follow real-time dynamical changes of mechanical properties of a material which can occur, e.g., in tissue engineering.
For instance, injury to articular cartilage is a common orthopedic problem, with more than one million surgical procedures being performed in the United States each year. Tissue engineering offers new strategies for repairing cartilage, for example, by using chondrocytes and scaffolds to promote a formation of new cartilage matrix that closely resembles native tissue. Cartilage has an important biomechanical function. Consequently, the biomechanical properties of a scaffold and the micromechanical environment it provides for the implanted cells can play a significant role in cartilage repair. Although conventional mechanical testing techniques are widely used for such scaffolds, they can be invasive, time consuming, and difficult to use in situ and in vivo.
Exemplary embodiments of the present invention may facilitate more sophisticated studies and uses, such as characterizing the micromechanical environment of implanted chondrocytes and their effects on new cartilage formation in vivo and over time. In order to assess the feasibility of applying dynamic visco-elastic characterization for such cartilage formation, Brillouin spectra of a type-I collagen gel (0.8 wt %) in 0.02N acetic acid solution and a photochemically cross-linked collagen-riboflavin mixture were measured.
Crosslinking of the gel was induced by illuminating with blue light for 40 sec. After crosslinking, strong Rayleigh scattering, appreciable even with the naked eye, was observed to dominate nearly the entire spectral window, which may prohibit an accurate detection of Brillouin peaks.
A tandem VIPA spectrometer may have a certain amount of a extinction to measure collagen cross-linking. In order to demonstrate this ability, it is possible to prepare two acidic solutions with about 3% and 6% collagen, and measure their Brillouin signatures with and without crosslinking. In this exemplary case, it may be preferable to use, e.g., Rose Bengal as a photo sensitizer; and the curing may occur with, e.g., 532 nm laser light.
Based on this exemplary data, Brillouin microscopy may be useful, e.g., in reviewing and determining the mechanical properties and their effects on chondrocytes-encapsulated collagen scaffolds and neocartilage formation in vitro as well as in vivo. Exemplary embodiments of the present invention may further be used to characterize living cells and tissues. However, stronger Rayleigh scattering arises in cells and tissue. An additional Rayleigh rejection efficiency of about 20-25 dB can be sufficient for tissue studies. Exemplary data may indicate that triple-VIPA spectrometer can be sufficient to achieve such exemplary task. Thus, Brillouin microscopy may be applied to biological tissues successfully. Water has a bulk modulus, E, of about 2.2 GPa at room temperature and a density, ρ, of about 1 g/cm3. Thus, e.g., at λ=532 nm, n=1.33, and θ=0°, and Δν=7.5 GHz. Since water is the most abundant molecule in biological tissue, studies show that biological tissue can exhibit Brillouin shifts in a range of about 2-20 GHz at λ=532 nm, as described in the J. M. Vaughan and J. T. Randall publication and the R. Harley, D. James, A. Miller, and J. W. White publication. Most biopolymers, such as PMMA or acrylate polymer, have Brillouin shifts also in the GHz range. Non-isotropic samples such as muscle or collagen fibers can produce multiple Brillouin shifts, which may depend on the scattering direction with respect to their symmetry axes, as described in N. Berovic, N. Thomas, R. A. Thornhill, and J. M. Vaughan, “Observation of Brillouin-Scattering from Single Muscle-Fibers,” European Biophysics Journal with Biophysics Letters, vol. 17, pp. 69-74, 1989.
The energy of an acoustic wave involved in spontaneous Brillouin scattering may be too weak to cause any significant biological perturbation. The Young's modulus and damping coefficient of a viscoelastic sample may be frequency dependent. Thus, such parameters measured by Brillouin spectroscopy in the GHz frequency range may be different from those measured by conventional strain-stress test or dynamic mechanical analysis, which may be typically performed from 0 Hz (e.g., using DC signals) to 100 Hz, as described in R. L. Y. Sah, Y. J. Kim, J. Y. H. Doong, A. J. Grodzinsky, A. H. K. Plaas, and J. D. Sandy, “Biosynthetic Response of Cartilage Explants to Dynamic Compression,” Journal of Orthopaedic Research, vol. 7, pp. 619-636, 1989. Most biological tissue and biopolymers can be viscoelastic and, consequently, the elasticity may vary considerably with strain rate and temperature. Therefore, it can be important to establish a correlation between Brillouin measurements and conventional mechanical measurements. In contrast, water has a very rapid relaxation time, shorter than about 10 ps, so its elastic modulus may not vary much from 0 Hz to 10 GHz.
Measuring viscoelastic properties of living tissues using Brillouin microscopy can provide a useful clinical non-invasive tool for the detection of early-stage cancers or intra-operative determination of tumor margins. Tumors may be generally stiffer than surrounding healthy tissue, and a Brillouin spectrum of a tumor can thereby exhibit a stronger magnitude than normal tissues at high frequencies. Atherosclerosis is another medical area the Brillouin microscopy may be used for characterizing stress and tissue compliance, e.g., to help identify plaques which may be at risk for causing an acute coronary event.
The foregoing merely illustrates the principles of the invention. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. Indeed, the arrangements, systems and methods according to the exemplary embodiments of the present invention can be used with any OCT system, OFDI system or other imaging systems, and for example with those described in U.S. Provisional Patent Appn. No. 60/514,769 filed Oct. 27, 2003, and International Patent Application No. PCT/US03/02349 filed on Jan. 24, 2003, the disclosures of which are incorporated by reference herein in their entireties. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements and methods which, although not explicitly shown or described herein, embody the principles of the invention and are thus within the spirit and scope of the present invention. In addition, to the extent that the prior art knowledge has not been explicitly incorporated by reference herein above, it is explicitly being incorporated herein in its entirety. All publications referenced herein above are incorporated herein by reference in their entireties. Exemplary references cited herein are as follows:
The invention was made with the U.S. Government support under Grant Number DAD17-02-2-0002 awarded by the U.S. Department of the Army. Thus, the U.S. Government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
2339754 | Brace | Jan 1944 | A |
3090753 | Matuszak et al. | May 1963 | A |
3601480 | Randall | Aug 1971 | A |
3856000 | Chikama | Dec 1974 | A |
3872407 | Hughes | Mar 1975 | A |
3941121 | Olinger | Mar 1976 | A |
3973219 | Tang et al. | Aug 1976 | A |
3983507 | Tang et al. | Sep 1976 | A |
4030827 | Delhaye et al. | Jun 1977 | A |
4140364 | Yamashita et al. | Feb 1979 | A |
4141362 | Wurster | Feb 1979 | A |
4224929 | Furihata | Sep 1980 | A |
4295738 | Meltz et al. | Oct 1981 | A |
4300816 | Snitzer et al. | Nov 1981 | A |
4303300 | Pressiat et al. | Dec 1981 | A |
4428643 | Kay | Jan 1984 | A |
4479499 | Alfano | Oct 1984 | A |
4533247 | Epworth | Aug 1985 | A |
4585349 | Gross et al. | Apr 1986 | A |
4601036 | Faxvog et al. | Jul 1986 | A |
4607622 | Fritch et al. | Aug 1986 | A |
4631498 | Cutler | Dec 1986 | A |
4650327 | Ogi | Mar 1987 | A |
4744656 | Moran et al. | May 1988 | A |
4751706 | Rohde et al. | Jun 1988 | A |
4770492 | Levin et al. | Sep 1988 | A |
4834111 | Khanna et al. | May 1989 | A |
4868834 | Fox et al. | Sep 1989 | A |
4890901 | Cross, Jr. | Jan 1990 | A |
4892406 | Waters | Jan 1990 | A |
4909631 | Tan et al. | Mar 1990 | A |
4925302 | Cutler | May 1990 | A |
4928005 | Lefèvre et al. | May 1990 | A |
4965441 | Picard | Oct 1990 | A |
4965599 | Roddy et al. | Oct 1990 | A |
4993834 | Carlhoff et al. | Feb 1991 | A |
5039193 | Snow et al. | Aug 1991 | A |
5040889 | Keane | Aug 1991 | A |
5045936 | Lobb et al. | Sep 1991 | A |
5046501 | Crilly | Sep 1991 | A |
5065331 | Vachon et al. | Nov 1991 | A |
5085496 | Yoshida et al. | Feb 1992 | A |
5120953 | Harris | Jun 1992 | A |
5121983 | Lee | Jun 1992 | A |
5127730 | Brelje et al. | Jul 1992 | A |
5197470 | Helfer et al. | Mar 1993 | A |
5202745 | Sorin et al. | Apr 1993 | A |
5212667 | Tomlinson et al. | May 1993 | A |
5214538 | Lobb | May 1993 | A |
5228001 | Birge et al. | Jul 1993 | A |
5248876 | Kerstens et al. | Sep 1993 | A |
5262644 | Maguire | Nov 1993 | A |
5291885 | Taniji et al. | Mar 1994 | A |
5293872 | Alfano et al. | Mar 1994 | A |
5293873 | Fang | Mar 1994 | A |
5304173 | Kittrell et al. | Apr 1994 | A |
5304810 | Amos | Apr 1994 | A |
5305759 | Kaneko et al. | Apr 1994 | A |
5317389 | Hochberg et al. | May 1994 | A |
5318024 | Kittrell et al. | Jun 1994 | A |
5321501 | Swanson et al. | Jun 1994 | A |
5353790 | Jacques et al. | Oct 1994 | A |
5383467 | Auer et al. | Jan 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5419323 | Kittrell et al. | May 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441053 | Lodder et al. | Aug 1995 | A |
5450203 | Penkethman | Sep 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5459325 | Hueton et al. | Oct 1995 | A |
5459570 | Swanson et al. | Oct 1995 | A |
5465147 | Swanson | Nov 1995 | A |
5486701 | Norton et al. | Jan 1996 | A |
5491524 | Hellmuth et al. | Feb 1996 | A |
5491552 | Kittrell | Feb 1996 | A |
5526338 | Hasman et al. | Jun 1996 | A |
5562100 | Kittrell et al. | Oct 1996 | A |
5565986 | Knüttel | Oct 1996 | A |
5583342 | Ichie | Dec 1996 | A |
5590660 | MacAulay et al. | Jan 1997 | A |
5600486 | Gal et al. | Feb 1997 | A |
5601087 | Gunderson et al. | Feb 1997 | A |
5621830 | Lucey et al. | Apr 1997 | A |
5623336 | Raab et al. | Apr 1997 | A |
5635830 | Itoh | Jun 1997 | A |
5649924 | Everett et al. | Jul 1997 | A |
5697373 | Richards-Kortum et al. | Dec 1997 | A |
5698397 | Zarling et al. | Dec 1997 | A |
5710630 | Essenpreis et al. | Jan 1998 | A |
5716324 | Toida | Feb 1998 | A |
5719399 | Alfano et al. | Feb 1998 | A |
5735276 | Lemelson | Apr 1998 | A |
5740808 | Panescu et al. | Apr 1998 | A |
5748318 | Maris et al. | May 1998 | A |
5748598 | Swanson et al. | May 1998 | A |
5784352 | Swanson et al. | Jul 1998 | A |
5785651 | Kuhn et al. | Jul 1998 | A |
5795295 | Hellmuth et al. | Aug 1998 | A |
5801826 | Williams | Sep 1998 | A |
5803082 | Stapleton et al. | Sep 1998 | A |
5807261 | Benaron et al. | Sep 1998 | A |
5817144 | Gregory | Oct 1998 | A |
5840023 | Oraevsky et al. | Nov 1998 | A |
5840075 | Mueller et al. | Nov 1998 | A |
5842995 | Mahadevan-Jansen et al. | Dec 1998 | A |
5843000 | Nishioka et al. | Dec 1998 | A |
5843052 | Benja-Athon | Dec 1998 | A |
5847827 | Fercher | Dec 1998 | A |
5862273 | Pelletier | Jan 1999 | A |
5865754 | Sevick-Muraca et al. | Feb 1999 | A |
5867268 | Gelikonov et al. | Feb 1999 | A |
5871449 | Brown | Feb 1999 | A |
5872879 | Hamm | Feb 1999 | A |
5877856 | Fercher | Mar 1999 | A |
5887009 | Mandella et al. | Mar 1999 | A |
5892583 | Li | Apr 1999 | A |
5912764 | Togino | Jun 1999 | A |
5920373 | Bille | Jul 1999 | A |
5920390 | Farahi et al. | Jul 1999 | A |
5921926 | Rolland et al. | Jul 1999 | A |
5926592 | Martin et al. | Jul 1999 | A |
5949929 | Hamm | Sep 1999 | A |
5951482 | Winston et al. | Sep 1999 | A |
5955737 | Hallidy et al. | Sep 1999 | A |
5956355 | Swanson et al. | Sep 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5983125 | Alfano et al. | Nov 1999 | A |
5987346 | Benaron et al. | Nov 1999 | A |
5991697 | Nelson et al. | Nov 1999 | A |
5994690 | Kulkarni et al. | Nov 1999 | A |
6002480 | Izatt et al. | Dec 1999 | A |
6004314 | Wei et al. | Dec 1999 | A |
6006128 | Izatt et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6014214 | Li | Jan 2000 | A |
6020963 | Dimarzio et al. | Feb 2000 | A |
6033721 | Nassuphis | Mar 2000 | A |
6044288 | Wake et al. | Mar 2000 | A |
6045511 | Lutz et al. | Apr 2000 | A |
6048742 | Weyburne et al. | Apr 2000 | A |
6053613 | Wei et al. | Apr 2000 | A |
6069698 | Ozawa et al. | May 2000 | A |
6091496 | Hill | Jul 2000 | A |
6091984 | Perelman et al. | Jul 2000 | A |
6111645 | Tearney et al. | Aug 2000 | A |
6117128 | Gregory | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6134003 | Tearney et al. | Oct 2000 | A |
6134010 | Zavislan | Oct 2000 | A |
6134033 | Bergano et al. | Oct 2000 | A |
6141577 | Rolland et al. | Oct 2000 | A |
6151522 | Alfano et al. | Nov 2000 | A |
6159445 | Klaveness et al. | Dec 2000 | A |
6160826 | Swanson et al. | Dec 2000 | A |
6161031 | Hochman et al. | Dec 2000 | A |
6166373 | Mao | Dec 2000 | A |
6174291 | McMahon et al. | Jan 2001 | B1 |
6175669 | Colston et al. | Jan 2001 | B1 |
6185271 | Kinsinger | Feb 2001 | B1 |
6191862 | Swanson et al. | Feb 2001 | B1 |
6193676 | Winston et al. | Feb 2001 | B1 |
6198956 | Dunne | Mar 2001 | B1 |
6201989 | Whitehead et al. | Mar 2001 | B1 |
6208415 | De Boer et al. | Mar 2001 | B1 |
6208887 | Clarke | Mar 2001 | B1 |
6245026 | Campbell et al. | Jun 2001 | B1 |
6249349 | Lauer | Jun 2001 | B1 |
6263234 | Engelhardt et al. | Jul 2001 | B1 |
6264610 | Zhu | Jul 2001 | B1 |
6272376 | Marcu et al. | Aug 2001 | B1 |
6274871 | Dukor et al. | Aug 2001 | B1 |
6282011 | Tearney et al. | Aug 2001 | B1 |
6297018 | French et al. | Oct 2001 | B1 |
6308092 | Hoyns | Oct 2001 | B1 |
6324419 | Guzelsu et al. | Nov 2001 | B1 |
6341036 | Tearney et al. | Jan 2002 | B1 |
6353693 | Kano et al. | Mar 2002 | B1 |
6359692 | Groot | Mar 2002 | B1 |
6377349 | Fercher | Apr 2002 | B1 |
6384915 | Everett et al. | May 2002 | B1 |
6393312 | Hoyns | May 2002 | B1 |
6394964 | Sievert, Jr. et al. | May 2002 | B1 |
6396941 | Bacus et al. | May 2002 | B1 |
6421164 | Tearney et al. | Jul 2002 | B2 |
6445485 | Frigo et al. | Sep 2002 | B1 |
6445944 | Ostrovsky | Sep 2002 | B1 |
6459487 | Chen et al. | Oct 2002 | B1 |
6463313 | Winston et al. | Oct 2002 | B1 |
6469846 | Ebizuka et al. | Oct 2002 | B2 |
6475159 | Casscells et al. | Nov 2002 | B1 |
6475210 | Phelps et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6485482 | Belef | Nov 2002 | B1 |
6501551 | Tearney et al. | Dec 2002 | B1 |
6501878 | Hughes et al. | Dec 2002 | B2 |
6538817 | Farmer et al. | Mar 2003 | B1 |
6549801 | Chen et al. | Apr 2003 | B1 |
6552796 | Magnin et al. | Apr 2003 | B2 |
6556305 | Aziz et al. | Apr 2003 | B1 |
6556853 | Cabib et al. | Apr 2003 | B1 |
6558324 | Von Behren et al. | May 2003 | B1 |
6564087 | Pitris et al. | May 2003 | B1 |
6564089 | Izatt et al. | May 2003 | B2 |
6567585 | Martin et al. | May 2003 | B2 |
6615071 | Casscells, III et al. | Sep 2003 | B1 |
6622732 | Constantz | Sep 2003 | B2 |
6680780 | Fee | Jan 2004 | B1 |
6685885 | Nolte et al. | Feb 2004 | B2 |
6687007 | Meigs | Feb 2004 | B1 |
6687010 | Horii et al. | Feb 2004 | B1 |
6687036 | Riza | Feb 2004 | B2 |
6701181 | Tang et al. | Mar 2004 | B2 |
6738144 | Dogariu et al. | May 2004 | B1 |
6741355 | Drabarek | May 2004 | B2 |
6790175 | Furusawa et al. | Sep 2004 | B1 |
6806963 | Wälti et al. | Oct 2004 | B1 |
6816743 | Moreno et al. | Nov 2004 | B2 |
6839496 | Mills et al. | Jan 2005 | B1 |
6903820 | Wang | Jun 2005 | B2 |
6949072 | Furnish et al. | Sep 2005 | B2 |
6980299 | de Boer | Dec 2005 | B1 |
7006231 | Ostrovsky et al. | Feb 2006 | B2 |
7061622 | Rollins et al. | Jun 2006 | B2 |
7190464 | Alphonse | Mar 2007 | B2 |
7231243 | Tearney et al. | Jun 2007 | B2 |
7242480 | Alphonse | Jul 2007 | B2 |
7267494 | Hongyu et al. | Sep 2007 | B2 |
7355716 | De Boer et al. | Apr 2008 | B2 |
7359062 | Chen et al. | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7391520 | Zhou et al. | Jun 2008 | B2 |
20010047137 | Moreno et al. | Nov 2001 | A1 |
20020016533 | Marchitto et al. | Feb 2002 | A1 |
20020052547 | Toida | May 2002 | A1 |
20020064341 | Fauver et al. | May 2002 | A1 |
20020076152 | Hughes et al. | Jun 2002 | A1 |
20020085209 | Mittleman et al. | Jul 2002 | A1 |
20020093662 | Chen et al. | Jul 2002 | A1 |
20020122246 | Tearney et al. | Sep 2002 | A1 |
20020133065 | Lucassen et al. | Sep 2002 | A1 |
20020140942 | Fee et al. | Oct 2002 | A1 |
20020158211 | Gillispie | Oct 2002 | A1 |
20020161357 | Rox et al. | Oct 2002 | A1 |
20020163622 | Magnin et al. | Nov 2002 | A1 |
20020172485 | Keaton et al. | Nov 2002 | A1 |
20020183623 | Tang et al. | Dec 2002 | A1 |
20020188204 | McNamara et al. | Dec 2002 | A1 |
20020196446 | Roth et al. | Dec 2002 | A1 |
20020198457 | Tearney et al. | Dec 2002 | A1 |
20030023153 | Izatt et al. | Jan 2003 | A1 |
20030026735 | Nolte et al. | Feb 2003 | A1 |
20030028114 | Casscells, III et al. | Feb 2003 | A1 |
20030082105 | Fischman et al. | May 2003 | A1 |
20030097048 | Ryan et al. | May 2003 | A1 |
20030108911 | Klimant et al. | Jun 2003 | A1 |
20030135101 | Webler | Jul 2003 | A1 |
20030164952 | Deichmann et al. | Sep 2003 | A1 |
20030171691 | Casscells, III et al. | Sep 2003 | A1 |
20030199769 | Podoleanu et al. | Oct 2003 | A1 |
20030216719 | Debenedictics et al. | Nov 2003 | A1 |
20030220749 | Chen et al. | Nov 2003 | A1 |
20030236443 | Cespedes et al. | Dec 2003 | A1 |
20040002650 | Mandrusov et al. | Jan 2004 | A1 |
20040054268 | Esenaliev et al. | Mar 2004 | A1 |
20040072200 | Rigler et al. | Apr 2004 | A1 |
20040077949 | Blofgett et al. | Apr 2004 | A1 |
20040086245 | Farroni et al. | May 2004 | A1 |
20040100631 | Bashkansky et al. | May 2004 | A1 |
20040100681 | Bjarklev et al. | May 2004 | A1 |
20040126048 | Dave et al. | Jul 2004 | A1 |
20040133191 | Momiuchi et al. | Jul 2004 | A1 |
20040150829 | Koch et al. | Aug 2004 | A1 |
20040152989 | Puttappa et al. | Aug 2004 | A1 |
20040166593 | Nolte et al. | Aug 2004 | A1 |
20040212808 | Okawa et al. | Oct 2004 | A1 |
20040239938 | Izatt | Dec 2004 | A1 |
20040263843 | Knopp et al. | Dec 2004 | A1 |
20050018201 | De Boer | Jan 2005 | A1 |
20050035295 | Bouma et al. | Feb 2005 | A1 |
20050046837 | Izumi et al. | Mar 2005 | A1 |
20050075547 | Wang | Apr 2005 | A1 |
20050083534 | Riza et al. | Apr 2005 | A1 |
20050165303 | Kleen et al. | Jul 2005 | A1 |
20050171438 | Chen et al. | Aug 2005 | A1 |
20060103850 | Alphonse et al. | May 2006 | A1 |
20060146339 | Fujita et al. | Jul 2006 | A1 |
20060155193 | Leonardi et al. | Jul 2006 | A1 |
20060244973 | Yun et al. | Nov 2006 | A1 |
20070019208 | Toida et al. | Jan 2007 | A1 |
20070276242 | Konofagou | Nov 2007 | A1 |
20070291277 | Everett et al. | Dec 2007 | A1 |
Number | Date | Country |
---|---|---|
4105221 | Sep 1991 | DE |
4309056 | Sep 1994 | DE |
19542955 | May 1997 | DE |
10351319 | Jun 2005 | DE |
0110201 | Jun 1984 | EP |
0251062 | Jan 1988 | EP |
0617286 | Feb 1994 | EP |
0590268 | Apr 1994 | EP |
0728440 | Aug 1996 | EP |
0933096 | Aug 1999 | EP |
1324051 | Jul 2003 | EP |
1426799 | Jun 2004 | EP |
1257778 | Dec 1971 | GB |
2030313 | Apr 1980 | GB |
2209221 | May 1989 | GB |
4135550 | May 1992 | JP |
4135551 | May 1992 | JP |
7900841 | Oct 1979 | WO |
9216865 | Oct 1992 | WO |
9219930 | Nov 1992 | WO |
9303672 | Mar 1993 | WO |
9533971 | Dec 1995 | WO |
9628212 | Sep 1996 | WO |
9732182 | Sep 1997 | WO |
9800057 | Jan 1998 | WO |
9801074 | Jan 1998 | WO |
9814132 | Apr 1998 | WO |
9835203 | Aug 1998 | WO |
9838907 | Sep 1998 | WO |
9846123 | Oct 1998 | WO |
9848838 | Nov 1998 | WO |
9848846 | Nov 1998 | WO |
9905487 | Feb 1999 | WO |
9944089 | Sep 1999 | WO |
9957507 | Nov 1999 | WO |
0058766 | Oct 2000 | WO |
0108579 | Feb 2001 | WO |
0127679 | Apr 2001 | WO |
0138820 | May 2001 | WO |
0142735 | Jun 2001 | WO |
0236015 | May 2002 | WO |
0238040 | May 2002 | WO |
0254027 | Jul 2002 | WO |
02084263 | Oct 2002 | WO |
03020119 | Mar 2003 | WO |
03046636 | Jun 2003 | WO |
03052478 | Jun 2003 | WO |
03062802 | Jul 2003 | WO |
03105678 | Dec 2003 | WO |
2004034869 | Apr 2004 | WO |
2004057266 | Jul 2004 | WO |
2004066824 | Aug 2004 | WO |
2004088361 | Oct 2004 | WO |
2004105598 | Dec 2004 | WO |
2005000115 | Jan 2005 | WO |
2005054780 | Jun 2005 | WO |
2005082225 | Sep 2005 | WO |
2006014392 | Feb 2006 | WO |
2006039091 | Apr 2006 | WO |
2006059109 | Jun 2006 | WO |
2006130797 | Dec 2006 | WO |
2007028531 | Mar 2007 | WO |
2007038787 | Apr 2007 | WO |
2007083138 | Jul 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20090323056 A1 | Dec 2009 | US |
Number | Date | Country | |
---|---|---|---|
60915990 | May 2007 | US |